Moxifloxacin and glucose homeostasis: A pooled-analysis of the evidence from clinical and postmarketing studies

Drug Safety

Volumn 27, Issue 9, 2004, Pages 671-686

  Gavin III, James R ^a   Kubin, Rolf ^b   Choudhri, Shurjeel ^c   Kubitza, Dagmar ^b   Himmel, Hebert ^b   Gross, Rainer ^b   Meyer, Jutta M ^b  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b BAYER PHARMA AG   (Germany)

^c BAYER CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; DOXYCYCLINE; GATIFLOXACIN; GLIBENCLAMIDE; GLUCOSE; INSULIN; LEVOFLOXACIN; MACROLIDE; MOXIFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TROVAFLOXACIN;

ANIMAL EXPERIMENT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; MALE; NONHUMAN; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; BLOOD GLUCOSE; CLINICAL TRIALS, PHASE II; CLINICAL TRIALS, PHASE III; DIABETES MELLITUS; GLUCOSE; HOMEOSTASIS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; MALE; PRODUCT SURVEILLANCE, POSTMARKETING; QUINOLINES; RATS;

EID: 3242794206     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200427090-00005     Document Type: Article

References (22)

1. Chan JC, Cockram CS, Critchley JA. Drug-induced disorders of glucose metabolism: mechanisms and management. Drug Saf 1996; 15 (2): 135-57
2. Pandit MK, Burke J, Gustafson AB, et al. Drug-induced disorders of glucose tolerance. Ann Intern Med 1993; 118: 529-39
3. Tsiodras S, Mantzoros C, Hammer S, et al. Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy. Arch Intern Med 2000; 160: 2050-6
4. Seltzer HS. Drug-induced hypoglycemia: a review of 1418 cases. Endocrinol Metab Clin North Am 1989; 18: 163-83
5. Marks V, Teale JD. Drug-induced hypoglycemia. Endocrinol Metab Clin North Am 1999; 28: 555-77
6. Luna B, Feinglos MN. Drug-induced hyperglycemia. JAMA 2001; 286: 1945-8
7. Dahn MS, Lange P. Hormonal changes and their influence on metabolism and nutrition in the critically ill. Intensive Care Med 1982; 8: 209-13
8. Bistrian BR. Hyperglycemia and infection: which is the chicken and which is the egg? J Parenter Enteral Nutr 2001; 25: 180-1
9. Iannini PB, Kubin R, Reiter C, et al. Reassuring safety profile of moxifloxacin. Clin Infect Dis 2001; 32: 1112-4
10. Tequin (gatifloxacin) tablets, Tequin (gatifloxacin) injection. Summary of product characteristics. Princeton (NJ): BristolMyers Squibb Company, 2002
11. Baker SE, Hangii MC. Possible gatifloxacin-induced hypoglycemia. Ann Pharmacother 2002; 36: 1722-6
12. Menzies DJ, Dorsainvil PA, Cunha BA, et al. Severe and persistent hypoglycemia due to gatifloxacin interaction with oral hypoglycaemic agents. Am J Med 2002; 113: 232-4
13. Parilo MA. Gatifloxacin-associated hypoglycemia. J Pharm Technol 2002; 18: 319-20
14. Ambrose PG, Bhavnani SM, Cirincioni B, Piedmonte M, Grasela TH. Gatifloxacin and the elderly: PK-PD analysis of age-related drug exposure. Presented at the 40th Annual Meeting of the Infectious Diseases Society of America; 2002 Oct 24-27; Chicago (IL)
15. Faich G, Morganroth J, Celesk R, et al. Excellent safety and efficacy profile of moxifloxacin: the Avelox clinical experience study and critical events committee for safety surveillance. Presented at the American Federation for Medical Research-Clinical Research Annual Meeting; 2001 Mar 8-11; Arlington (VA)
16. Landen H, Moller M, Tillotson GS, et al. Clinical experience in Germany of treating community-acquired respiratory infections with the new 8-methoxyfluoroquinolone, moxifloxacin. J Int Med Res 2001; 29: 51-60
17. Landen H, Bauer T. Efficacy, onset of action and tolerability of moxifloxacin in patients with community acquired pneumonia. Clin Drug Invest 2001; 21: 801-11
18. Bauer T, Landen H. Rapid resolution of symptoms with moxifloxacin therapy in 7223 patients with acute exacerbation of chronic bronchitis. Clin Drug Invest 2002; 22: 641-51
19. Landen H, Bauer T, Stauch K. Therapy of acute exacerbations of chronic bronchitis with moxifloxacin in pneumological practice. European Congress on Clinical Microbiology and Infectious Disease; 2002, Milan, Italy
20. Johansen O, Sundsfjord J, Vaaler S, et al. Haemorrhage-induced increases in glucose, glucagon and insulin levels are blocked by naloxone in rats. Eur J Surg 1994; 160: 403-7
21. Panten U, Schwanstecher M, Schwanstecher C. Oral antidiabetics. In: Kuhlmann J, Puls W, editors. Handbook of experimental pathology. Berlin: Springer, 1996, 129-159
22. Gajjar DA, LaCreta FP, Kollia GD, et al. Effect of multiple-dose gatifloxacin or ciprofloxacin on glucose homeostasis and insulin production in patients with noninsulin-dependent diabetes mellitus maintained with diet and exercise. Pharmacotherapy 2000; 20: 76S-86S